| Description | Vatelizumab (GBR500), a monoclonal antibody, specifically targets the α2 subunit (CD49b) of very late antigen-2 (VLA-2) and is utilized in multiple sclerosis research [1]. |
| Synonyms | GBR500 |
| molecular weight | N/A |
| CAS | 1238217-55-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |